Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target profile describes a complex of reactive chemical species and catalysts—specifically reactive carbonyl compounds (RCCs), oxygen-centered radicals (ROS), and catalytic transition metal ions—that collectively drive the progression of oxidative and carbonyl stress [1]. RCCs like methylglyoxal and malondialdehyde are potent electrophiles that modify proteins to form advanced glycation end-products (AGEs), while oxygen-centered radicals like the hydroxyl radical cause direct oxidative damage to DNA and lipids [2, 3]. Catalytic metal ions, such as iron and copper, act as essential cofactors that amplify this damage by facilitating the production of radicals through Fenton and Haber-Weiss chemistry [4]. While not a single protein target, this chemical network is a major therapeutic focus in metabolic and neurodegenerative diseases, where drugs like aminoguanidine and pyridoxamine are designed to scavenge these reactive intermediates or chelate the metal catalysts [5, 6]. Targeting this system aims to prevent the irreversible cross-linking of proteins and the inflammatory signaling cascades triggered by oxidative damage.
Scavenging of electrophilic carbonyls, neutralization of free radicals, and chelation of redox-active metal ions to prevent the formation of advanced glycation end-products and oxidative cellular damage.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive carbonyl compounds, oxygen-centered radicals, and catalytic metal ions (RCCs, ROS, and metal ions).